MilanaPharm Receives Notice of Allowance from U.S. Patent Office For Lidocaine Topical Formulation
09. Mai 2019 10:11 ET
|
MilanaPharm
TALLASSEE, Ala., May 09, 2019 (GLOBE NEWSWIRE) -- MilanaPharm, a specialty pharmaceutical company focused on the development of innovative, non-opioid pharmaceutical solutions for wound management...